A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions?

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 4, 2011, Pages 378-382

  Kurpad, Raj ^a   Kim, William ^a   Rathmell, W Kim ^a   Godley, Paul ^a   Whang, Young ^a   Fielding, Julia ^a,b   Smith, LuAnn ^a   Pettiford, Ava ^a   Schultz, Heather ^a   Nielsen, Matthew ^a   Wallen, Eric M ^a   Pruthi, Raj S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Multidisciplinary; Prostate cancer; Renal cell carcinoma; Treatment decisions; Urothelial carcinoma

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL DECISION MAKING; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PENIS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; TESTIS CANCER; UROGENITAL TRACT CANCER;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICAL ONCOLOGY; PATIENT CARE TEAM; PROSPECTIVE STUDIES; UROLOGIC NEOPLASMS;

EID: 79959861599     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.04.008     Document Type: Article

References (12)

1. McNair A.G., Choh C.T., Metcalfe C., et al. Maximizing recruitment into randomized controlled trials: The role of multidisciplinary cancer teams. Eur J Cancer 2008, 44:2623-2626.
2. Westin T., Stalfors J. Tumor boards/multidisciplinary head and neck cancer meetings: Are they of value to patients, treating staff, or a political additional drain on healthcare resources?. Curr Opin Otolaryngol Head Neck Surg 2008, 16:103-107.
3. August D.A., Carpenter L.C., Harness J.K., et al. Benefits of a multidisciplinary approach to breast care. J Surg Oncol 1993, 53:161-167.
4. Nguyen N.P., Vos P., Lee H., et al. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Oncology 2008, 75:186-191.
5. Sidhom M.A., Poulsen M.G. Multidisciplinary care in oncology: Medicolegal implications of group decisions. Lancet Oncol 2006, 7:951-954.
6. Leo F., Venissac N., Poudenx M., et al. Multidisciplinary management of lung cancer: How to test its efficacy?. J Thorac Oncol 2007, 2:69-72.
7. Acher P.L., Young A.J., Etherington-Foy R., et al. Improving outcomes in urological cancers: The impact of "multidisciplinary team meetings.". Int J Surg 2005, 3:121-123.
8. Sharma A., Sharp D.M., Walker L.G., et al. Colorectal MDTs: The team's perspective. Colorectal Dis 2008, 10:63-68.
9. Harrison J.D., Choy E.T., Spillane A., et al. Australian breast cancer specialists' involvement in multidisciplinary treatment planning meetings. Breast 2008, 17:335-340.
10. Belldegrun A.S., Klatte T., Shuch B., et al. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): A benchmark for emerging targeted cancer therapies. Cancer 2008, 113:2457-2463.
11. Calabrò F., Sternberg C.N. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer. Eur Urol 2009, 55:348-358.
12. Gonzalez J.R., Laudano M.A., McCann T.R., et al. A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies. World J Urol 2008, 26:475-480.